Maria C. Cid
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 163 publications
Evidence-based guidelines for the diagnosis and management of adult-onset IgA vasculitis.
Journal: Nature reviews. Rheumatology
Published: July 28, 2026
Activation of HIF2 in Cardiac Vasculature Leads to Arterial Remodeling, Dilation, Thrombosis, and Inflammation, Recapitulating Cardiac Involvement in Kawasaki Disease.
Journal: Circulation
Published: June 08, 2026
Activation of HIF2 in Cardiac Vasculature Leads to Arterial Remodeling, Dilation, Thrombosis, and Inflammation, Recapitulating Cardiac Involvement in Kawasaki Disease.
Journal: Circulation
Published: June 08, 2026
Treatment strategies in giant cell arteritis and polymyalgia rheumatica: beyond glucocorticoids.
Journal: Nature reviews. Rheumatology
Published: April 17, 2026
Changing Patterns in Hospitalisations of Patients with Systemic Lupus Erythematosus over Three Decades at a Tertiary Referral Centre in Catalonia.
Journal: Journal of clinical medicine
Published: April 01, 2026
2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis.
Journal: Annals of the rheumatic diseases
Published: March 31, 2026
Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.
Journal: Annals of the rheumatic diseases
Published: March 25, 2026
Clinical outcomes of upadacitinib continuation vs withdrawal in giant cell arteritis through 2 years.
Journal: Annals of the rheumatic diseases
Published: March 14, 2026
Higher complement C4 gene copy number constitutes a shared genetic risk factor for giant cell arteritis and IgA vasculitis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 19, 2026
A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritis.
Journal: Seminars in arthritis and rheumatism
Published: November 22, 2025
Mepolizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A scoping review of effectiveness and safety data derived from real-world evidence.
Journal: Autoimmunity reviews
Published: October 02, 2025
A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritis.
Journal: Annals of the rheumatic diseases
Published: September 15, 2025
Last Updated: 09/26/2026